Regeneron Pharmaceuticals
In Thomas Gayner's portfolio · Markel Group
Ticker REGN
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Markel Group 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q3 2022 | No change | 80,300 | 0.8% |
| Q2 2022 | No change | 80,300 | 0.7% |
| Q1 2022 | Add 1% | 80,300 | 0.7% |
| Q4 2021 | Add 7% | 79,300 | 0.6% |
| Q3 2021 | Add 11% | 74,300 | 0.6% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.